Loading
Life sciences · Journal article
Acs Applied Bio Materials · October 9, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Radiotherapy (RT) remains a cornerstone in lung cancer management, yet its efficacy is often compromised by radiation resistance and off-target toxicity. Metal halide perovskites exhibit high potential for biomedical applications owing to their exceptional fluorescence imaging and photoelectric conversion capabilities, offering distinct radiosensitization advantages via high-Z elements and radiation-excited electron‒hole pairs. However, their poor physiological stability and limited biocompatibility have hindered biomedical translation. Herein, we construct an optimized multifunctional perovskite quantum dot (PQD) modified with chitosan-folate (CS-FA) (Cs-Sn-Pb-Br@CS-FA), which maintains long-term retention of photoluminescence and optical absorption properties in water for over 200 days, enabling specific tumor lesion tracing. Upon X-ray irradiation, the Cs-Sn-Pb-Br@CS-FA can promote the generation of multiple reactive oxygen species (ROS) through photoelectrocatalytically-induced electron‒hole pair separation and triplet energy transfer (TET). Moreover, the generated holes can simultaneously deplete endogenous glutathione (GSH), amplifying ROS accumulation and enhancing radiotherapeutic efficiency to promote tumor cell death. Biosafety assessment verified minimal toxicity to normal tissues at therapeutic doses, with intact fluorescent nanoparticles excreted via feces in their undecomposed perovskite form. In vivo study further underscored the dual functionality of the Cs-Sn-Pb-Br@CS-FA for precise tumor fluorescence imaging and effective radiosensitization in anti-tumor therapy. This work expands the biomedical application horizons of metal halide perovskites.